806 Results from VIITAL: A phase 3, randomized, intrapatient-controlled trial of an investigational collagen type VII gene–corrected autologous cell therapy, EB-101, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB)
| Autor: | Tang, J.Y., Marinkovich, M.P., Wiss, K., McCarthy, D., Truesdale, A., Chiou, A.S., McIntyre, J.K., Moore, A., Grachev, I. |
|---|---|
| Zdroj: | In Journal of Investigative Dermatology May 2023 143(5) Supplement:S138-S138 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|